Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for Asthenia in Palliative Cancer Care
NCT00273741Phase 3Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in asthenia, sponsored by CHU Grenoble Alpes. Started Jan 2007; status: terminated.
02
Drugs
methylphenidate
03
Conditions
asthenia
Beyond the preview
Go deeper on NCT00273741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273741.